These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 202418)

  • 21. [Vaccination against poliomyelitis].
    Cellesi C; Rossolini A
    Pediatr Med Chir; 1984; 6(1):13-5. PubMed ID: 6099548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies against poliomyelitis and measles viruses in immunized and unimmunized children, Ghana 1976-78.
    Böttiger M; Litvinov S; Assaad F; Lundbeck H; Heller L; Beausoleil EG
    Bull World Health Organ; 1981; 59(5):729-36. PubMed ID: 6976234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccine control of poliomyelitis in the 1980s.
    Sabin AB
    Yale J Biol Med; 1982; 55(3-4):383-9. PubMed ID: 7180028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Observations on children vaccinated orally with triple anti-poliomyelitis vaccine].
    Kocińska-Sypczyńska D
    Przegl Epidemiol; 1976; 30(1):53-8. PubMed ID: 179117
    [No Abstract]   [Full Text] [Related]  

  • 25. Recommendations for a national policy on poliomyelitis vaccination.
    Nightingale EO
    N Engl J Med; 1977 Aug; 297(5):249-53. PubMed ID: 195207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of oral poliomyelitis vaccine: results of a WHO enquiry.
    Esteves K
    Bull World Health Organ; 1988; 66(6):739-46. PubMed ID: 3266113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Isolates of poliovirus vaccine and immune response to different doses of oral polio vaccine].
    Más Lago P; Díaz J; Díaz Gonzalez M; Goyenechea Hernández A; Barrio Olivera J; Fonseca Quintana M; Morier Díaz L; Sarmiento Pérez L; Palomera Puente R
    Rev Cubana Med Trop; 2005; 57(2):111-9. PubMed ID: 17966580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Post-vaccination anti-poliomyelitis seroprevalence in an urban setting in Abidjan].
    Akoua-Koffi G; Thonnon J; Kouassi-Renaud M; Dosso M; Ehouman A
    Bull Soc Pathol Exot; 1995; 88(3):117-20. PubMed ID: 8555765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poliovirus antibodies in age groups: an assessment of obligatory vaccination in Belgium.
    Lamy ME; Cornu C; Desmyter J
    Dev Biol Stand; 1979; 43():207-13. PubMed ID: 230111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The spread of the wild Poliovirus in the rural environment, the case of the Adzopé health district, Côte d'Ivoire].
    Akoua-Koffi CG; Nekouressi G; Tieoulou L; Guillot S; Faye-Kette H; Ehouman A
    Bull Soc Pathol Exot; 2004 May; 97(2):87-90. PubMed ID: 15255346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poliomyelitis in Japan during the period 1962-68 after the introduction of mass vaccination with Sabin vaccine.
    Takatsu T; Tagaya I; Hirayama M
    Bull World Health Organ; 1973; 49(2):129-37. PubMed ID: 4545320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody to poliovirus in older children and young adults in Israel and the use of poliovaccines for the immunization of the seronegatives.
    Goldblum N; Kra-Oz Z; Swartz T
    Dev Biol Stand; 1979; 43():173-7. PubMed ID: 230108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotype-specific mucosal immune response and subsequent poliovirus replication in vaccinated children.
    Samoilovich E; Roivainen M; Titov LP; Hovi T
    J Med Virol; 2003 Oct; 71(2):274-80. PubMed ID: 12938203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination against poliomyelitis in economically underdeveloped countries.
    Sabin AB
    Bull World Health Organ; 1980; 58(1):141-57. PubMed ID: 6966544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A comparison of the effectiveness of mass immunization campaign of trivalent oral poliovirus vaccine (TOPV) by epidemiological serosurvey. Shandong Collaborating Group for Poliomyelitis Control and Surveillance, Jinan, Shandong].
    Xu A
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):261-4. PubMed ID: 1338626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Need for polio boosters after age two years.
    Rennels MB
    Vaccine; 2009 Jan; 27(2):179-80. PubMed ID: 19007837
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of 2 different regimens for reactogenicity, safety, and immunogenicity of the live attenuated oral rotavirus vaccine RIX4414 coadministered with oral polio vaccine in South African infants.
    Steele AD; Reynders J; Scholtz F; Bos P; de Beer MC; Tumbo J; Van der Merwe CF; Delem A; De Vos B
    J Infect Dis; 2010 Sep; 202 Suppl():S93-100. PubMed ID: 20684724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Poliomyelitis in New Caledonia: epidemiological data, post-vaccinal seroconversion, prophylactic strategy].
    Louis JP; Panon G; Le Gonidec G
    Med Trop (Mars); 1985; 45(3):223-33. PubMed ID: 2999557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Booster effect of Sabin poliomyelitis vaccine.
    Teplý V; Srámová H; Svandová E
    Bull World Health Organ; 1976; 54(6):681-4. PubMed ID: 1088514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.